Canada Biotechnology & Medical Research

Hemostemix Inc (HEM)

Track

Hemostemix Inc. recorded one insider trading transaction over the past ninety days, involving a purchase of 2,000,000 shares by director Peter Alan Lacey. This activity follows the company's May 2026 results financiers. The stock price has risen 16.7% recently, remaining well below its annual peak despite ongoing accumulation by board members.
Ticker: HEM Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hemostemix Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
211.37
Quantity 51,333 -31.2%
Value CA$3,022,004
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
156.33
Quantity 83,167 +14.7%
Value CA$66,666
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
70.70
Quantity 45,981 +37.7%
Value CA$2,186,757
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 1,000 +0.5%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 1,000 +11.1%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.06
Quantity 1,000 +28.7%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.06
Quantity 1,000 -87.5%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.09
Quantity 1,000 -71.7%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 1,000 +702.8%
Value CA$100,000
1.5
Smeenk, Thomas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 20,000 +0.3%
Value CA$1,700
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 1,000,000 +102.3%
Value CA$110,000
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 1,500,000 +59.8%
Value CA$165,000
Swanberg, Loran Director of Issuer Non-Executive Director
Transaction date
Planned purchase
Price
0.11
Quantity 500,000 +57.8%
Value CA$55,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 260,000 +1.2%
Value CA$19,500
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 200,000 +0.9%
Value CA$15,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.08
Quantity 400,000 +1.9%
Value CA$30,000
1.5
Smeenk, Thomas Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.12
Quantity 200,000 +5.1%
Value CA$23,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 1,000 +15.9%
Value CA$100,000
Swanberg, Loran Lavern Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 1,000 +46.2%
Value CA$100,000
2.5
Lacey, Peter Alan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 15,000,000 +254.2%
Value CA$1,500,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-06-26 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
51,333 -31.2%
211.37
CA$3,022,004 		51,333 -31.2% 211.37 CA$3,022,004
2026-06-28 2026-06-25 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
83,167 +14.7%
156.33
CA$66,666 		83,167 +14.7% 156.33 CA$66,666
2026-08-10 2026-06-10 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
45,981 +37.7%
70.70
CA$2,186,757 		45,981 +37.7% 70.70 CA$2,186,757
2026-08-10 2026-06-10 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +0.5%
0.06
CA$100,000 		1,000 +0.5% 0.06 CA$100,000
2026-08-10 2026-06-10 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +11.1%
0.06
CA$100,000 		1,000 +11.1% 0.06 CA$100,000
2026-08-10 2026-05-20 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +28.7%
0.06
CA$100,000 		1,000 +28.7% 0.06 CA$100,000
2026-08-10 2026-05-20 S Sale
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 -87.5%
0.06
CA$100,000 		1,000 -87.5% 0.06 CA$100,000
2026-08-10 2026-02-09 S Sale
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 -71.7%
0.09
CA$100,000 		1,000 -71.7% 0.09 CA$100,000
2026-08-10 2026-02-09 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +702.8%
0.09
CA$100,000 		1,000 +702.8% 0.09 CA$100,000
2025-12-16 2025-12-16 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
20,000 +0.3%
0.09
CA$1,700 		20,000 +0.3% 0.09 CA$1,700
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
1,000,000 +102.3%
0.11
CA$110,000 		1,000,000 +102.3% 0.11 CA$110,000
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
1,500,000 +59.8%
0.11
CA$165,000 		1,500,000 +59.8% 0.11 CA$165,000
2025-11-04 2025-11-03 PP Planned purchase
Swanberg, Loran

Director of Issuer

Non-Executive Director
500,000 +57.8%
0.11
CA$55,000 		500,000 +57.8% 0.11 CA$55,000
2025-08-19 2025-08-18 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
260,000 +1.2%
0.08
CA$19,500 		260,000 +1.2% 0.08 CA$19,500
2025-08-13 2025-08-11 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
200,000 +0.9%
0.08
CA$15,000 		200,000 +0.9% 0.08 CA$15,000
2025-08-13 2025-08-08 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
400,000 +1.9%
0.08
CA$30,000 		400,000 +1.9% 0.08 CA$30,000
2025-08-06 2025-08-05 B Purchase
1.5
Smeenk, Thomas

Director of Issuer

Non-Executive Director
200,000 +5.1%
0.12
CA$23,000 		200,000 +5.1% 0.12 CA$23,000
2026-08-10 2025-07-23 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +15.9%
0.10
CA$100,000 		1,000 +15.9% 0.10 CA$100,000
2026-08-10 2025-07-23 B Purchase
Swanberg, Loran Lavern

Director of Issuer

Non-Executive Director
1,000 +46.2%
0.10
CA$100,000 		1,000 +46.2% 0.10 CA$100,000
2025-07-25 2025-07-23 B Purchase
2.5
Lacey, Peter Alan

Director of Issuer

Non-Executive Director
15,000,000 +254.2%
0.10
CA$1,500,000 		15,000,000 +254.2% 0.10 CA$1,500,000
Explore more

More insider trading research around Hemostemix Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America